Sign up for Your
FREE Subscription
Your First Name:
Your E-mail:

What's Old Is New Again:


By Nurse Mark

This one is from the "how can we put a positive "spin" on something that we've been pooh-poohing for so long" department...

Researchers at a recent meeting of the American Society of Clinical Oncology in Chicago are now touting the benefits of arsenic - long used in Traditional Chinese Medicine - for the treatment of certain forms cancer.

It seems that the US based drug company Cephalon Inc has received approval for it's drug Trisenox to be used in people with acute promyelocytic leukemia. How long can it be before other "off-label" uses are promoted? This drug was purchased by Cephalon in 2005 for a reported 70 million dollars in cash and promises of up to $100 million more in future payments. There is some Big Money involved!

So, a fairly natural substance, known and used for millennia by the Chinese but considered "fringe medicine" - unacceptable by western allopathic "scientific" (read: drug-based) standards - has now been patented and is being marketed by a US drug company. Has the substance, arsenic, changed? Nope. What has changed is the "ownership" of the substance. And now that profits are involved this formerly feared substance is being spun into a lifesaving treatment for one of mankind's most dread illnesses.

This all makes me wonder how long it will be before that other ancient treatment for cancer, laetrile, is "discovered" and brought into the light of respectability once again.

You see, in the 1970's laetrile compounds were being researched and said to be effective in the treatment of cancer. Not just a little bit helpful, but really, really effective. Unfortunately, major players in the Cancer Industry such as Memorial Sloan-Kettering Cancer Center and the FDA and it's handlers in Big Pharma have been successful in villainizing this compound, making much of the fact that it contains a form of cyanide. The mighty FDA has prosecuted this compound and those who would use it mercilessly.

Why should this be so? Could it be that a substance that actually works could damage the profitability of the Cancer Industry? After all, if a handful of apricot seeds could accomplish that which obscenely expensive chemotherapy treatments cannot this would be a major blow to the Pharmaceutical Giants...

So, I'm predicting that we'll not see any drug company pursue research into laetrile, at least not publicly. It would be far too embarrassing for them to discover good about this after so much effort has gone into "proving" it to be bad.

Curing cancer is not in the cards - there is far too much money at stake.

We might see something like laetrile from Big Pharma, but only if it can be patented, and only if it doesn't work much better than the chemotherapies that they have now. That's my admittedly cynical opinion...

References and additional reading:

News Release: Cephalon, Inc. Announces Acquisition of TRISENOX(R) from Cell Therapeutics, Inc. 06/13/2005. Transaction Accelerates Cephalon's Entry into Oncology Market and Builds Platform for its Growing Oncology Franchise.


Vitamin B17 (Laetrile) Cancer Cure Cover up


Inside HealthBeat

Meet Our Team
Contact Us
Readers Rants


DISCLAIMER: Consuming the information provided in HealthBeat may cause reduced side-effects, increased knowledge, improved health and well-being and the potential for enhanced common-sense. Use at your own risk. These statements have not been evaluated or blessed by the FDA, The Big Drug Companies, or Big Medicine and are not intended to diagnose, treat or cure any disease or medical condition. None of the suggestions made herein are intended to take the place of your personal physician, shaman, chiropractor or other healthcare provider. Please be aware that statements made herein could result in a loss of profits to the FDA, Big Pharma and Big Medicine and should be used cautiously with this in mind. These statements contain no appreciable amounts of calories, carbohydrates, sodium or cholesterol and are certified to be free of all trans-fats.